Skip to main content

Life Sciences

Interest In AI And Cognitive Is Rising In Pharma

Artificial intelligence (AI), cognitive computing, and machine learning are becoming more common in the industry. The need to scour and analyze large sets of data is giving life sciences companies new intelligence that would never have been realized before. The technology is making a big impact on healthcare decisions and patients.

Life Sciences - How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process
How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process

Learn how AI/ML can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.

Get the Guide

When it comes to addiction and substance abuse, patient risk models are helping predict and prevent incidents of relapse. Artificial intelligence is helping doctors identify treatment options while providing supporting evidence. While AI is driving precision medicine, it’s also being used by pharmaceutical companies to gain insight into consumer behavior and expectations.

Jason Andree, senior brand manager of the Cough & Cold Portfolio at GlaxoSmithKline North America, shared how GSK is using cognitive technology to promote its Theraflu brand. The company is using IBM Watson to enable consumers to interact with advertisements within a mobile app, by asking questions (through voice or text) related to the flu or the Theraflu product.

To learn about other trends that we can also expect to see in 2018, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Eugene Sefanov

Director, Industry and Regional Marketing

More from this Author

Follow Us